Low-Density Lipoprotein Receptor-Related Protein-1 (LRP1) C4408R Mutant Promotes Amyloid Precursor Protein (APP) α-Cleavage in Vitro
- 13 June 2017
- journal article
- research article
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 19 (2-3) , 300-308
Abstract
Previous studies have demonstrated that the low-density lipoprotein receptor-related protein-1 (LRP1) plays conflicting roles in Alzheimer’s disease (AD) pathogenesis, clearing β-amyloid (Aβ) from the brain while also enhancing APP endocytosis and resultant amyloidogenic processing. We have recently discovered that co-expression of mutant LRP1 C-terminal domain (LRP1-CT C4408R) with Swedish mutant amyloid precursor protein (APPswe) in Chinese hamster ovary (CHO) cells decreases Aβ production, while also increasing sAPPα and APP α-C-terminal fragment (α-CTF), compared with CHO cells expressing APPswe alone. Surprisingly, the location of this mutation on LRP1 corresponded with the α-secretase cleavage site of APP. Further experimentation confirmed that in CHO cells expressing APPswe or wild-type APP (APPwt), co-expression of LRP1-CT C4408R decreases Aβ and increases sAPPα and α-CTF compared with co-expression of wild-type LRP1-CT. In addition, LRP1-CT C4408R enhanced the unglycosylated form of LRP1-CT and reduced APP endocytosis as determined by flow cytometry. This finding identifies a point mutation in LRP1 which slows LRP1-CT-mediated APP endocytosis and amyloidogenic processing, while enhancing APP α-secretase cleavage, thus demonstrating a potential novel target for slowing AD pathogenesis.Keywords
This publication has 43 references indexed in Scilit:
- The acetylation of tau inhibits its function and promotes pathological tau aggregationNature Communications, 2011
- Signaling through LRP1: Protection from atherosclerosis and beyondBiochemical Pharmacology, 2011
- Decreased Clearance of CNS β-Amyloid in Alzheimer’s DiseaseScience, 2010
- Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brainJournal of Neurochemistry, 2010
- SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cellsNature Cell Biology, 2008
- apoE isoform–specific disruption of amyloid β peptide clearance from mouse brainJournal of Clinical Investigation, 2008
- LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout StudiesPhysiological Reviews, 2008
- Clearance of amyloid-β by circulating lipoprotein receptorsNature Medicine, 2007
- The cytoplasmic domain of the LDL receptor‐related protein regulates multiple steps in APP processingThe EMBO Journal, 2002
- LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradationCell, 1995